Effects of Combined CCR5/Integrase Inhibitors-Based Regimen on Mucosal Immunity in HIV-Infected Patients Naïve to Antiretroviral Therapy: A Pilot Randomized Trial.

Serrano-Villar, Sergio

Effects of Combined CCR5/Integrase Inhibitors-Based Regimen on Mucosal Immunity in HIV-Infected Patients Naïve to Antiretroviral Therapy: A Pilot Randomized Trial. [electronic resource] - PLoS pathogens Jan 2016 - e1005381 p. digital

Publication Type: Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

1553-7374

10.1371/journal.ppat.1005381 doi


Adult
Alkynes
Anti-HIV Agents--administration & dosage
Benzoxazines--administration & dosage
CCR5 Receptor Antagonists--administration & dosage
Chromatography, High Pressure Liquid
Cyclohexanes--administration & dosage
Cyclopropanes
Drug Combinations
Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination--administration & dosage
Enzyme-Linked Immunosorbent Assay
Female
Flow Cytometry
HIV Infections--drug therapy
HIV Integrase Inhibitors--administration & dosage
Humans
Immunity, Mucosal--drug effects
Lymphocyte Activation--drug effects
Male
Maraviroc
Pilot Projects
Raltegravir Potassium--administration & dosage
T-Lymphocyte Subsets--drug effects
Triazoles--administration & dosage